DC3 Therapeutics
South San Francisco, CA, United States dc3therapeutics.com From their website, Nov 2026
- GLP
- CLIA
Work here? Claim this listing
About
DC3 Therapeutics is a CRO that supports discovery through preclinical and clinical-stage development for biotech and pharma clients. It operates from South San Francisco, California and provides assay, biomarker, pathology, diagnostic, and consulting support.
DC3 Therapeutics is a CRO in South San Francisco, CA, founded in 2013. It lists 6 services, including Cell & Molecular Biology, Biochemical, Biophysical & Cell-Based Assays and Protein Chemistry & Biochemistry. It names GLP and CLIA on its listing.
Services
Cell & Molecular Biology
Supports advanced cell engineering, genomic manipulation, molecular profiling, cell line generation, transfection, gene editing, cloning, nucleic acid purification, sequencing, and mycoplasma and sterility testing.
Biochemical, Biophysical & Cell-Based Assays
Develops and runs functional validation and screening assays including apoptosis, viability, reporter gene, enzymology, signaling, metabolism, protein-protein interaction, and compound screening assays.
Protein Chemistry & Biochemistry
Provides recombinant protein expression, purification, yield optimization, and functional protein assays using bacterial, mammalian, and baculovirus systems.
Protein production
IHC & Spatial Biology
Performs tissue processing, histology, immunohistochemistry, immunofluorescence, in situ hybridization, fluorescence in situ hybridization, digital pathology, and image analysis.
Clinical Chemistry
Offers COLA-accredited and CLIA-certified testing and biomarker analysis across multiple matrices, plus custom lab-developed tests.
Program Management & Consulting
Provides study design, interpretation, planning, and cross-functional support for discovery, preclinical, IND-enabling, and clinical programs.
How to order from DC3 Therapeutics
They take quote requests by email. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Cell-based assays
- Small molecules
- NGS
- CRISPR
- Insect cells
- Biomarker assays
14 more
- Companion diagnostics
- Lab-developed tests (LDTs)
- Target validation
- Mechanism of action studies
- Pre-clinical / IND-enabling studies
- Cell line generation and authentication
- RNAi knockdown
- CRISPR/Cas9 genome editing
- TALEN genome editing
- Apoptosis assays
- Necrosis assays
- Viability assays
- Cytotoxicity assays
- Reporter gene assays
- Scale and capacity
- 96- and 384-well formats
- 100K pharmaceutically active compound library
Instruments and platforms
- qRT-PCR
- dPCR
- Sanger sequencing
- Next-generation sequencing (NGS)
- Digital pathology
Modalities and species
- Modalities
- Small molecule
- Gene editing
- Recombinant protein
- Species and models
- Insect cells
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: IND submission support
CLIASelf-reported
Scope: lab environment / custom LDTs / biomarker and clinical testing
Details
- Type
- CRO
- Founded
- 2013
- Ownership
- Small business · Minority-owned, as registered with SAM.gov or stated on their site
- Address
- 163 West Harris Avenue, South San Francisco, CA 94080
Public records
- Biocom California CRO directory
- assay development, Biomarker Analysis, Cell & Molecular Biology, CLIA & Public Health Laboratory, Gene Expression, Spatial Biology source